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The main focus of the current review is the nitric oxide (NO)-mediated signaling
mechanism in unloaded skeletal. Review of the published data describing muscles during
physical activity and inactivity demonstrates that NO is an essential trigger of signaling
processes, which leads to structural and metabolic changes of the muscle fibers. The
experiments with modulation of NO-synthase (NOS) activity during muscle unloading
demonstrate the ability of an activated enzyme to stabilize degradation processes and
prevent development of muscle atrophy. Various forms of muscle mechanical activity,
i.e., plantar afferent stimulation, resistive exercise and passive chronic stretch increase
the content of neural NOS (nNOS) and thus may facilitate an increase in NO production.
Recent studies demonstrate that NO-synthase participates in the regulation of protein
and energymetabolism in skeletal muscle by fine-tuning and stabilizing complex signaling
systems which regulate protein synthesis and degradation in the fibers of inactive muscle.
Keywords: skeletal muscle, unloading, nitric oxide (II), NO-synthase, protective function of NO
Recent studies have highlighted a critical role of NO in the complex signaling regulation in
functional muscle fibers. In the present review we summarize role of NO and NOS in anabolic
and catabolic signaling processes in skeletal muscle under conditions of elevated and decreased
contractile activity.
NO interacts with cell components using three main mechanisms. First, NO reacts with
molecular oxygen and superoxide anions, producing a number of low-molecular NO derivatives
(Nox) which possess redox activity and are capable of participation in electron transportation
reactions (Stamler et al., 1992). The reaction between NO and superoxide anions leads to the
production of peroxynitrites, the most reactive free-radical molecules in biological systems which
are often used as indicators of oxidative stress (Freeman, 1994). Skeletal muscle produces small
amounts of NO and superoxide anions under normal physiological conditions. Secondly, NO
derivatives react with metal-transporters such as haem iron and iron-sulfide centers producing
NO-metal complexes. NO can also regulate the function of metalloproteins. For example, the
NO-haem bond increases soluble guanylate cyclase activity in muscle, raising the concentration
of cyclic guanosine monophosphate (cGMP) (Kobzik et al., 1994). Third, reduced thiols are the
main targets of NO. NO reacts with thiols of proteins (RSH, RS−) through S-nitrosylation. Thus,
S-nitrosylation of glutathione and other non-regulatory thiols represents another mechanism of
NO buffering by the cells. This reaction can also regulate protein function through conformational
changes by increasing disulfide formation, or through reacting with the nearest centers containing
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metal atoms (Stamler, 1994). Activation of the two main NO-
mediated signaling processes depends on guanylate cyclase
activation and protein S-nitrosylation.
ISOFORMS OF NOS AND REGULATION OF
nNOS ACTIVITY
Synthesis of NO is catalyzed by NOS. Three NOS isoforms
are known: type I or neuronal NOS (nNOS) is continuously
expressed in different neuronal structures and in muscles;
type II is inducible NOS (iNOS) which usually is not
present in muscle cells; type III endothelial NOS (eNOS)
is expressed in endothelial cells (Lancaster and Hibbs, 1990;
Forstermann et al., 1994). nNOS and eNOS are calcium-
dependent, iNOS is calcium-independent and is transcriptionally
regulated by different cytokines (Hevel et al., 1991; Stuehr
et al., 1991). nNOS and eNOS are regulated by intracellular
Ca2+ levels through Ca2+-dependent binding of NOS to
the calcium-calmodulin complex (CaM). nNOS and eNOS
initiate activation at a Ca2+ concentration of about 100 nmol/L,
and are fully activated at 500 nmol/L of Ca2+ (Förstermann
et al., 1990, 1991; Pollock et al., 1991; Schmidt et al.,
1991).
Several isoforms/splice-variants of nNOS are known. nNOSµ
is the most well-studied splice variant of nNOS in rat skeletal
muscle (Alderton et al., 2001). The main bulk of NO is produced
by the nNOSµ isoform in skeletal muscle. It is localized to
the subsarcolemmal zone and is associated with dystrophin-
sarcoglican complex of cytoskeletal proteins. nNOSµ can also
be associated with the cytoskeletal complex at the nuclear
membrane (Aquilano et al., 2014). nNOS activity, i.e., its
ability to produce NO, is regulated by phosphorylation on the
serine residue by insulin-activated protein kinases (Hinchee-
Rodriguez et al., 2013) or AMP-dependent protein kinase
(AMPK) (Chen et al., 2000). A decrease in NO production
is, most likely, caused by calpain-dependent degradation of
nNOS or its export out of the subsarcolemmal complex (Lainé
and de Montellano, 1998; Crosbie et al., 2002). Heat shock
protein 90 (HSP90) plays a critical role in nNOS activation and
stability (Bender et al., 1999; Kone et al., 2003; Piech et al.,
2003; Papapetropoulos et al., 2004). HSP90 regulates nNOS
activity through positive allosteric modulation, leading to the
formation of active nNOS conformation or by an increase in
nNOS affinity for the calcium-calmodulin complex (CaM) (Song
et al., 2001). It was previously reported that nNOS interaction
with HSP90 regulates insertion of a haem-group (Minami et al.,
1994; Billecke et al., 2002). Blockade of HSP90 causes inhibition
of nNOS activity and generation of monomer haem-deficit
nNOS which undergoes rapid proteasome degradation (Osawa
et al., 2003; Dunbar et al., 2004). Moreover, HSP90 regulates
degradation of nNOS by calpain (Averna et al., 2007). NOS
substrate, the precursor of NO—L-arginine is reported to be
the NOS activator while L-NAME (N-nitro-L-arginine methyl
ester hydrochloride) is its competitive inhibitor. Both of these
compounds regulate nNOS and eNOS isoforms expressed in
skeletal muscle.
REGULATION OF THE EXPRESSION AND
LOCALIZATION OF NEURONAL NOS IN
SKELETAL MUSCLE
nNOS is expressed in skeletal muscle fibers and in the axons
of motoneurons (Nakane et al., 1993). Immunohistochemistry
reveals higher concentrations of nNOS in fast, when compared
with slow skeletal muscle fibers (Kobzik et al., 1994). nNOS is
usually located near the sarcolemma, and its content is very high
at the neuromuscular junctions (Brenman et al., 1996). However,
it can also be found in the cytoplasm of muscle fibers as an
unbound molecule. In the sarcolemmal zone, nNOS is associated
with α1-syntrophin of the dystrophin-sarcoglycan complex
(Brenman et al., 1995; Wakayama et al., 1997). This association
depends on the presence of thePDZ domain of syntrophin
(Adams et al., 2001). Sarcolemmal localization of several other
proteins such as aquaporin-4 and mechano-sensitive calcium
channel TRPC-1 also depends on the presence of the PDZ
domain of syntrophin (Adams et al., 2001; Vandebrouck et al.,
2007). nNOSµ, bound to the dystrophin-sarcoglycan complex,
was also found inside the inner membrane of the myonuclear
envelope (Aquilano et al., 2014).
FUNCTION OF NO IN A CONTRACTING
MUSCLE
During increased muscle contractile activity NO production
in muscle (Perez et al., 2002; Vassilakopoulos et al., 2003) as
well as NO content in blood (with verified muscle origin) is
increased (Perez et al., 2002). Rue and colleagues (2007) reported
a 48% increase in the NO content during contraction of a
single muscle fiber (Pye et al., 2007). This increase of NO
content was not observed in the presence of L-NAME, a NOS
inhibitor. Zhang et al. (2004) found, that NO is produced in
C2C12 skeletal muscle cells during static or dynamic stretching
(Zhang et al., 2004). Repeated physical exercises lead to elevated
nNOS expression (Tatchum-Talom et al., 2000; McConell et al.,
2007). However, the nature of the mechano-dependent nNOS
activation still remains unknown. The signaling role of NO
during increased muscles contractile activity has not been
well studied. L-NAME (NOS inhibitor) prevented a fast-to-
slow fiber type transition during chronic electrostimulation of
muscles in rats (Martins et al., 2012). This suggests the existence
of synergetic effects of NO and calcineurin/NFAT signaling
pathways on the regulation of myosin heavy chain expression.
Indeed, the authors demonstrated that NO suppresses GSK3β via
activation of the guanylate cyclase pathway and that this prevents
nuclear export of NFATc1. As a result, increased NO production
in the contracting muscle promotes a high level of expression of
slow myosin heavy chain isoform.
NO is known to stimulate AMPK (5′-AMP-dependent protein
kinase) in skeletal muscle. This increases energy supplies
in muscle during aerobic exercise; including biogenesis of
mitochondria, activation of β-oxidation of fatty acids, as well
as insulin-dependent and insulin-independent glucose transport
(Lira et al., 2007, 2010; Deshmukh et al., 2010). Moreover, similar
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to AMPK, NO is an effective inhibitor of histone deacetylases
(Watson and Riccio, 2009) promoting expression of many
muscle-specific proteins critical for the contractile activity.
ROLES OF NO IN ACTIVITY-DEPENDENT
MUSCLE HYPERTROPHY
Most of scientists support the idea that two known mechanisms
underlying development of activity-dependent muscle
hypertrophy are: (1) activation of translation mediated by
the protein kinase complex mTORC1, and (2) activation of
satellite cell proliferation followed by their differentiation and
fusion with neighboring muscle fibers, increasing the number
of myonuclei (Bodine, 2006; Bruusgaard et al., 2010). The role
of NOS activity in activity-dependent muscle hypertrophy is
supported by the muscle compensatory loading in synergist
removal experiments. L-NAME administration decreases the
level of muscle hypertrophy in these experiments (Zhang et al.,
2004). A complete block of the increase in slow myosin heavy
chains and α-actin expression was also observed under these
conditions (Sellman et al., 2006).
Increased NO production was recently shown to activate
signaling pathways promoting mTORC1 activity (Ito et al., 2013).
According to the data obtained by several research groups, NOS
activation during muscle stretching or resisting exercise initiates
proliferation of G0-satellite cells (Anderson and Wozniak,
2004; Yamada et al., 2006, 2008; Tatsumi, 2010). Released NO
passes through the sarcolemma, and activates hepatocyte growth
factor (HGF) through the activity of matrix metalloproteinases.
Activated HGF interacts with c-met receptors of satellite cells,
promoting their entrance into the cell cycle. Therefore, during
resistance exercises NO works as an activator and as a regulator
of signaling, and sometimes as a trigger of muscle hypertrophy.
REGULATION OF THE
CALPAIN-MEDIATED CYTOSKELETAL
PROTEOLYSIS
Michetti et al. (1995) described an inhibition of proteolytic
activity of µ-calpain of skeletal muscle by iNOS in vitro. NO can
also prevent multiple effects of calcium ionophores on C2C12
muscle cells, which include degradation of vinculin, intercellular
junction proteins, and decrease of total protein content. These
effects of NO are mediated by the inhibition of µ-calpain activity
via the cysteine S-nytrosylation. Experiments using cell cultures
showed that NO also regulates calpain-dependent degradation of
cytoskeletal proteins (Koh and Tidball, 2000). Zhang et al. (2004)
reproduced these experiments with some modifications. They
found that 10% stretching in C2C12 cells increases NO content
and nNOS activity, increased synthesis of talin, vinculin, and
desmin, and to concomitant fiber stiffness (Zhang et al., 2004).
These effects are enhanced by the administration NO precursor
L-arginine and by calpain inhibitors, and are blocked by the NO-
synthase inhibitor L-NAME. In summary, these data suggest the
existence of a significant crosstalk between NOS activity and NO
production on one side, and the status of cytoskeletal proteins on
the other.
GRAVITATIONAL UNLOADING OF
SKELETAL MUSCLE: NO PRODUCTION,
nNOS CONTENT AND LOCALIZATION
Experiments using rat tail suspension (Tidball et al., 1998;
Suzuki et al., 2007), prolonged bed-rest or immersion of human
volunteers (Moukhina et al., 2004; Rudnick et al., 2004) showed
that total nNOS content is decreased during gravitational
unloading. A decrease of nNOS content in muscle fibers also
was observed in mice subjected to weightlessness onboard the
International Space Station during a 90-day flight (Sandonà
et al., 2012). nNOS mRNA expression was also decreased during
simulated gravitational unloading (Lomonosova et al., 2011).
We previously reported a decrease of NO levels in rat soleus
muscle after 2 weeks of unloading (Lomonosova et al., 2011).
This result is in a disagreement with the data from Suzuki et al.
(2007) who demonstrated increases in NO in combination with
a pronounced decrease of total nNOS content in mouse soleus
muscle after 14 days of tail suspension. At the same time, levels
of NO in nNOS knockout mice and in mice treated with nNOS
inhibitor were the same as in control wild type mice (Suzuki
et al., 2007). Suzuki and colleagues explained the increase of
NO concentration in muscle fibers in their experiments by a
translocation of NOS from the membrane to the cytoplasm. This
phenomenon was observed on multiple occasions, but currently
there are no published data documenting higher NO production
by non-membrane-bound NOS. Since both studies (Suzuki et al.,
2007; Lomonosova et al., 2011) used the same experimental
approach measuring of NO levels the observed discrepancies
need further examination.
Sarcolemmal nNOS content was recently shown to be
decreased during gravitational unloading (Sandonà et al.,
2012). This was associated with protein degradation and with
translocation of a part of the nNOS to the cytosolic compartment
(Suzuki et al., 2007; Sandonà et al., 2012; Sun et al., 2013; Liu et al.,
2014). Lawler and colleagues demonstrated, that administration
of EUK-134 blocked nNOS dissociation from the sarcolemma
and its translocation to the cytosolic compartment during 54-
h unloading experiments (Lawler et al., 2014). This protected
pFOXO3a (phospho-Forkhead transcription factor) from de-
phosphorylation, and as a result prevented atrophy of soleus
muscle and slow-to-fast shift in muscle fiber type (Lawler et al.,
2014). These effects could be attributed to prevention of the
decrease of total nNOS content due to the changes in nNOS
activity related to its release from the sarcolemma. Moreover,
nNOS is translocated not only to the cytoplasm, but also to
the nucleus along with α-syntrophin (Aquilano et al., 2014). It
was noted that altered nNOS splicing and nuclear localization
could be a contributing factor in pathology of muscular diseases
in humans. Data from Blottner’s group demonstrated that after
prolonged hypokinesia, not only did nNOS content decrease
but also total levels of protein nitrosylation were diminished in
human soleus and vastus lateralis muscles (Salanova et al., 2008).
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GRAVITATIONAL UNLOADING OF
SKELETAL MUSCLE: EFFECTS OF NO ON
DEGRADATION OF CYTOSKELETAL
PROTEINS
Unloading leads to the destruction of cytoskeletal and contractile
proteins. These changes are usually attributed to increased
activity of calcium-dependent proteases calpains. Increased
concentration of calcium ions in the sarcoplasm was recently
demonstrated at the early stages of gravitational unloading
(Ingalls et al., 1999; Shenkman and Nemirovskaya, 2008) along
with increased expression of µ-calpain and decreased expression
of calpostatin, an endogenous inhibitor of calpains (Ma et al.,
2011; Lomonosova et al., 2012b). Yet, Tidball’s group (Samengo
et al., 2012) found sufficient content of calpain in muscle
fibers of young mice to support active proteolysis. In their
experiments calpain molecules in muscles of young mice were
nitrosylated and did not possess their typical level of proteolytic
activity. To the contrary, old animals had lowered levels
of nitrosylation, correlated with increased calpain proteolytic
activity and decreased content of cytoskeletal proteins. The
described experiments clarify possible mechanisms of calpain
activation during conditions of decreased nNOS activity.
Our experiments with administration of the natural NO
precursor L-arginine demonstrated prevention of calpain-
dependent hydrolysis of cytoskeletal proteins during unloading.
In Figure 1, we presented the proposed mechanism of nNOS-
induced effects on protein degradation in skeletal muscle during
unloading. We hypothesize that lowered NO concentration in
muscle during unloading can cause reduced S-nitrosylation
of calpains. This leads to calpain activation and to the
degradation of cytoskeletal and contractile proteins, resulting
in muscle atrophy. To test our hypothesis we administered
L-arginine to rats during unloading experiments. Two weeks
of unloading decreased NO concentration in muscle, while
L-arginine administration prevented any NO decrease and
diminished atrophy of soleus muscle. Moreover, L-arginine
supplementation prevented the decrease of several cytoskeletal
proteins (desmin and dystrophin) in rat soleus muscle during
unloading (Lomonosova et al., 2011). Administration of the NO
precursor also prevented an increase in the mRNA expression
levels of E3-ubiquitin ligases (atrogin-1/MAFbx, MuRF-1—
muscle RING-finger protein-1) during unloading.
Recent experiments demonstrated a role for NO as an
endogenous inhibitor of 26S proteasomes (Liu et al., 2014). The
main function of the proteasome is to degrade unnecessary or
damaged proteins by proteolysis. Therefore, lack of increase in
the expression of E3-ubiquitin ligases after administration of
L-arginine during unloading can be related to a decrease of
calpain activity. There are several explanations for the increased
expression of ubiquitine ligases due to the activation ofµ-calpain
(Smith and Dodd, 2007) and calpain P94 (Kramerova et al.,
2005). nNOS activity can be also modulated through crosstalk
with other regulatory proteins, including heat shock protein
90 (HSP90). Interaction with HSP90 increases nNOS activity
and protects cytoskeletal proteins from ubiquitin proteasome
degradation (Peng et al., 2009). Under normal conditions skeletal
muscle contains high amounts of HSP90 proteins which become
significantly decreased during skeletal muscle atrophy (Sakurai
et al., 2005; Sõti et al., 2005; Seo et al., 2006). In our study on
the administration NO precursor L-arginine during unloading
we have not observed a loss of HSP90 content in skeletal
muscles of rats administered L-arginine (Lomonosova et al.,
2011). Therefore, the decrease of soleus muscle atrophy in our
experiments could be in part, the result of HSP90 protection
of muscle proteins from ubiquitin proteasome degradation.
Thus, activation of NO-dependent pathways can inhibit the
signaling systems regulating protein degradation in muscle
during unloading, supporting a critical role of NO signaling in
these conditions.
FIGURE 1 | Mechanismof nNOS effects on protein metabolism in skeletal muscle during unloading.
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TABLE 1 | NO-related responses in active and unloaded muscle.
Active muscle Ref. Unloaded muscle Ref.
NO content High 36,37, 38 Low 62
nNOS
content
High 40,41 Low 57–66
NO inhibits
calpain-
induced
protein
degradation
Yes 47,56 No 62
NO maintains
slow myosin
phenotype
Yes 42 No 62
NO maintains
satellite cells
proliferation
Yes 51–54 No 82–84
GRAVITATIONAL UNLOADING OF
SKELETAL MUSCLE: EFFECTS OF NO ON
FIBER TYPE COMPOSITION
Unloading is known to stimulate expression of the fast isoforms
of myosin heavy chains (MHC) leading to changes in contractile
properties of soleus muscle. Unexpectedly, in our study we
found that L-arginine administration also prevented a decrease
of slowMHC expression levels in soleusmuscle during unloading
(Lomonosova et al., 2011). This data demonstrates a critical role
of nNOS in the regulation of contractile protein expression.
Based on the data on inhibition of the calcineurin/NFAT by
GSK3β and its regulation by the NO-induced cyclic guanosine
monophosphate pathway (Martins et al., 2012), we hypothesized
that increases in NO content after L-arginine administration
in our experiments prevents slow-to-fast transition in soleus
muscles of rats.
GRAVITATIONAL UNLOADING OF
SKELETAL MUSCLE: EFFECTS OF
MECHANICAL ACTIVITIES ON nNOS
Most of scientists link alterations in skeletal muscles following
unloading with a lack of muscle contractile activity or with
decreased resistive components of muscle contraction (Falempin
and Mounier, 1998). The same can be said about changes in
the NO-dependent signaling pathways. Interestingly, mechanical
stimulation of a plantar supporting zone with concurrent
increases of electric activity of soleus (Grigoriev et al., 2004)
prevents a loss of nNOS during immersion experiments. These
data demonstrate the dependence of NOS content on muscle
contractile activity (Moukhina et al., 2004). Resistance physical
exercise during hypokinesia also blocks decreases of protein
nitrosylation levels (Rudnick et al., 2004). Therefore, decreased
muscle contractile activity leads to a loss of nNOS content and
activity. Chronic passive stretching is often used to simulate
the loading component of muscle contraction. We hypothesized
that nNOS can participate in atrophy prevention in soleus
muscle under conditions of stretching combined with rat tail
suspension.
To test our hypothesis, we blocked NOS with L-NAME during
stretching combined with unloading (Lomonosova et al., 2012a).
Muscle membrane stretching induces nNOS activity (Deshmukh
et al., 2010) preventing an increase in the activity of calpains,
expression of E3-ubiqutin ligases, and protein ubiquitination
during unloading. The content of nNOS is not decreased during
stretching combined with unloading (Lomonosova et al., 2012a;
Xu et al., 2012). If our hypothesis is correct, administration
of the nNOS blocker L-NAME during stretching, combined
with unloading would result in muscle atrophy. However, in
our study, NOS inhibition in stretched soleus muscle during
rat tail suspension does not cause muscle atrophy. In fact,
the level of E3-ubiquitin ligases was not increased in any
of the tail suspended rats in our experiments with stretched
soleus muscle with or without inhibition of NOS activity. We
concluded that NO-dependent signaling is not critical for the
maintenance of muscle mass in stretched soleus muscle during
unloading. At the same time, muscle stretching during unloading
completely prevented the decrease of slow and increase of
fast MHC expression (Falempin and Mounier, 1998). L-NAME
administration neutralized this effect of stretching, supporting
a role of NO in preserving MHC expression during muscle
stretching, combined with unloading.
Some authors have linked increased muscle mass with the
higher content of myonuclei and activation of the satellite cells
in muscle (Wang et al., 2006; Shenkman et al., 2010). A decrease
in NO concentration was previously reported to lower the ability
of satellite cells to proliferate. An increase in the number of
satellite cells was prevented by administration of L-NAME in
stretched muscle (Shenkman et al., 2010). This suggests that
satellite cell activation and proliferation is a NO-dependent
process (Kartashkina et al., 2010).
CONCLUSION
Exogenous activation of nNOS and probably other NOS isoforms
leads to an increase in NO production. This can block damage
and atrophic processes in skeletal muscle, as well as changes in the
expression of myosin isoforms under unloading conditions. The
expression and content of NOS is decreased during unloading
and this coincides with decrease in NO production. Based on
these findings, we hypothesize that a reduction of NOS and
NO production promotes muscle atrophy. Our hypothesis is
supported by recent studies demonstrating that NO-synthase
participates in the regulation of protein turnover in skeletal
muscle by fine-tuning and stabilizing signaling pathways that
regulate protein synthesis and degradation in the muscle fibers
of inactive muscle (Table 1).
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